You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult male

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Male Participants Trial (BMS-986322)

Not yet recruiting
  • Healthy Male Participants
  • (no location specified)
Oct 12, 2023

Healthy Male Subjects Trial in Lincoln (14C RPT193)

Not yet recruiting
  • Healthy Male Subjects
  • 14C RPT193
  • Lincoln, Nebraska
    Celerion
Oct 13, 2023

Healthy Trial in Beijing (Macitentan, Placebo)

Recruiting
  • Healthy
  • Beijing, China
    Peking University Third Hospital
Jul 18, 2023

Opioid Use Disorder Trial ([14C]IDV184001AN)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Aug 1, 2023

Influenza, Human Trial (ZX-7101A 80mg)

Not yet recruiting
  • Influenza, Human
  • ZX-7101A 80mg
  • (no location specified)
Feb 6, 2023

COVID-19 Trial in Beijing ([14C]STI-1558)

Not yet recruiting
  • COVID-19
  • Beijing, China
    Beijing Gaobo Boren Hospital
Mar 1, 2023

Healthy Male Subjects Trial in Tokyo (TAS-303, [14C]TAS-303)

Active, not recruiting
  • Healthy Male Subjects
  • TAS-303, [14C]TAS-303
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Nov 17, 2022

Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)

Completed
  • Peripheral Analgesic and Anti-itch
  • Suzhou, Jiangsu, China
    f the First Affiliated Hospital of soochow University
Apr 19, 2023

Healthy Adult Male Volunteers Trial in Suzhou ([14C]SHR1459)

Active, not recruiting
  • Healthy Adult Male Volunteers
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 27, 2022

Healthy Volunteers Trial in Leiden (BIIB115, BIIB115-Matching Placebo)

Recruiting
  • Healthy Volunteers
  • Leiden, Netherlands
    Centre For Human Drug Reasearch
Nov 16, 2022

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Cerebral Adrenoleukodystrophy (cALD) Trial in Argentina, Brazil, United States (Leriglitazone, Placebo)

Not yet recruiting
  • Cerebral Adrenoleukodystrophy (cALD)
  • Palo Alto, California
  • +6 more
Apr 5, 2023

Male Hemophilia B Previously Treated With Etranacogene

Not yet recruiting
  • Hemophilia B
  • AAV5-hFIXco-Padua
  • (no location specified)
Jul 31, 2023

AGA Trial in Zhejiang (CU-40101)

Not yet recruiting
  • AGA
  • Zhejiang, Hangzhou, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 26, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 2, 2023

Amyotrophic Lateral Sclerosis (Healthy Volunteers) Trial in Saint Paul (SAR443820, Erythromycin ethyl succinate, Itraconazole)

Completed
  • Amyotrophic Lateral Sclerosis (Healthy Volunteers)
  • Saint Paul, Minnesota
    Nucleus Network-Site Number:8400001
Mar 22, 2023

Erectile Dysfunction Trial in Brisbane (Testofen 300mg, Testofen 600mg, Placebo comparator)

Recruiting
  • Erectile Dysfunction
  • Testofen 300mg
  • +2 more
  • Brisbane, Queensland, Australia
    RDC Clinical Pty Ltd
May 18, 2022

Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)

Completed
  • Respiratory Syncytial Virus Infections
  • 200 mg RV521/78 µCi [ 14C]-RV521.
  • Baltimore, Maryland
    Pharmaron Clinical Pharmacology Center
May 15, 2023

Healthy Trial in Groningen (14C-aticaprant)

Completed
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Apr 27, 2022

Healthy Individuals Trial in Karachi (Anplag (Ticagrelor 90 mg), Brilinta (Ticagrelor 90 mg))

Completed
  • Healthy Individuals
  • Anplag (Ticagrelor 90 mg)
  • Brilinta (Ticagrelor 90 mg)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Sep 5, 2022

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Pharmacokinetics Trial in Suzhou ([14C] ZSP1273)

Active, not recruiting
  • Pharmacokinetics
  • [14C] ZSP1273
  • Suzhou, China
    The First affiliated hospital of Suzhou university
May 15, 2023